These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 21514366)

  • 1. Neurosteroid and GABA-A receptor alterations in Alzheimer's disease, Parkinson's disease and multiple sclerosis.
    Luchetti S; Huitinga I; Swaab DF
    Neuroscience; 2011 Sep; 191():6-21. PubMed ID: 21514366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review.
    Marecki R; Kałuska J; Kolanek A; Hakało D; Waszkiewicz N
    Front Psychiatry; 2023; 14():1298359. PubMed ID: 38116383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell specificity dictates similarities in gene expression in multiple sclerosis, Parkinson's disease, and Alzheimer's disease.
    Itoh Y; Voskuhl RR
    PLoS One; 2017; 12(7):e0181349. PubMed ID: 28715462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroactive steroids and Parkinson's disease: Review of human and animal studies.
    Bourque M; Morissette M; Di Paolo T
    Neurosci Biobehav Rev; 2024 Jan; 156():105479. PubMed ID: 38007170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurosteroids (allopregnanolone) and alcohol use disorder: From mechanisms to potential pharmacotherapy.
    Gatta E; Camussi D; Auta J; Guidotti A; Pandey SC
    Pharmacol Ther; 2022 Dec; 240():108299. PubMed ID: 36323379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current View on PPAR-α and Its Relation to Neurosteroids in Alzheimer's Disease and Other Neuropsychiatric Disorders: Promising Targets in a Therapeutic Strategy.
    Żulińska S; Strosznajder AK; Strosznajder JB
    Int J Mol Sci; 2024 Jun; 25(13):. PubMed ID: 39000217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental and adult stress: effects of steroids and neurosteroids.
    Gore IR; Gould E
    Stress; 2024 Jan; 27(1):2317856. PubMed ID: 38563163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders.
    Balan I; Boero G; Chéry SL; McFarland MH; Lopez AG; Morrow AL
    Life (Basel); 2024 Apr; 14(5):. PubMed ID: 38792602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel neuroactive steroids as positive allosteric modulators of NMDA receptors: mechanism, site of action, and rescue pharmacology on GRIN variants associated with neurological conditions.
    Tang W; Beckley JT; Zhang J; Song R; Xu Y; Kim S; Quirk MC; Robichaud AJ; Diaz ES; Myers SJ; Doherty JJ; Ackley MA; Traynelis SF; Yuan H
    Cell Mol Life Sci; 2023 Jan; 80(2):42. PubMed ID: 36645496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurosteroids: A potential target for neuropsychiatric disorders.
    Wang M; Hu S; Fu X; Zhou H; Yang S; Yang C
    J Steroid Biochem Mol Biol; 2024 May; 239():106485. PubMed ID: 38369032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosteroid enantiomers as potentially novel neurotherapeutics.
    Covey DF; Evers AS; Izumi Y; Maguire JL; Mennerick SJ; Zorumski CF
    Neurosci Biobehav Rev; 2023 Jun; 149():105191. PubMed ID: 37085023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of neurosteroids on neuronal survival: molecular basis and clinical perspectives.
    Leśkiewicz M; Budziszewska B; Basta-Kaim A; Zajac A; Kaciński M; Lasoń W
    Acta Neurobiol Exp (Wars); 2006; 66(4):359-67. PubMed ID: 17265696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative and Qualitative Analysis of Neurotransmitter and Neurosteroid Production in Cerebral Organoids during Differentiation.
    Park SB; Koh B; Kwon HS; Kim YE; Kim SS; Cho SH; Kim TY; Bae MA; Kang D; Kim CH; Kim KY
    ACS Chem Neurosci; 2023 Oct; 14(20):3761-3771. PubMed ID: 37796021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into neurosteroids and their role in women with epilepsy.
    Vadlamudi L; Ashley DP; Voinescu PE
    Front Glob Womens Health; 2024; 5():1363470. PubMed ID: 38933454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurosteroid and neurotransmitter alterations in Parkinson's disease.
    di Michele F; Luchetti S; Bernardi G; Romeo E; Longone P
    Front Neuroendocrinol; 2013 Apr; 34(2):132-42. PubMed ID: 23563222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allopregnanolone: state of the art.
    Melcangi RC; Panzica GC
    Prog Neurobiol; 2014 Feb; 113():1-5. PubMed ID: 24121112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of functional GABA(A) receptors in the Alzheimer diseased brain.
    Limon A; Reyes-Ruiz JM; Miledi R
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):10071-6. PubMed ID: 22691495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic Alzheimer's disease: the starving brain.
    Mamelak M
    J Alzheimers Dis; 2012; 31(3):459-74. PubMed ID: 22571985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurosteroids as regulators of neuroinflammation.
    Yilmaz C; Karali K; Fodelianaki G; Gravanis A; Chavakis T; Charalampopoulos I; Alexaki VI
    Front Neuroendocrinol; 2019 Oct; 55():100788. PubMed ID: 31513776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The two-directional prospective association between inflammatory bowel disease and neurodegenerative disorders: a systematic review and meta-analysis based on longitudinal studies.
    Zong J; Yang Y; Wang H; Zhang H; Yang X; Yang X
    Front Immunol; 2024; 15():1325908. PubMed ID: 38720896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.